Corrigendum to "A narrative review of approved and emerging anti-obesity medications" [Saudi Pharm. J. 31(10) (2023) 101757]

Saudi Pharm J. 2024 May;32(5):102047. doi: 10.1016/j.jsps.2024.102047. Epub 2024 Apr 5.

¹ Department of clinical pharmacy and Pharmacotherapeutics, Dubai Pharmacy College For Girls, Dubai, United Arab Emirates.
² Program of Clinical Pharmacy, College of Pharmacy, Al Ain University, Abu Dhabi Campus, United Arab Emirates.
³ AAU Health and Biomedical Research Centre, Al Ain University, Abu Dhabi, United Arab Emirates.
⁴ College of Medicine, Gulf Medical University, Ajman, United Arab Emirates.
⁵ College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.
⁶ Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
⁷ Department of Pharmaceutical Sciences, College of Pharmacy, 105949, Al Ain University, Al Ain, United Arab Emirates.
⁸ AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.
⁹ Chief Operation Officer, Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, United Arab Emirates.
¹⁰ Department of clinical pharmacy and Therapeutics, Dubai Pharmacy College, Dubai, United Arab Emirates.
¹¹ Department of Clinical Pharmacy and Pharmacy Practice, (PhD, MSc, B Pharm), College of Pharmacy, Najran University, Najran -King Saudi Arabia (KSA), Saudi Arabia.
¹² Fourth-year pharmacy, Abu Dhabi, United Arab Emirates.
¹³ College of Pharmacy, Al Ain University, Abu Dhabi Campus, United Arab Emirates.

Abstract

[This corrects the article DOI: 10.1016/j.jsps.2023.101757.].